- 专利标题： Cathepsin cysteine protease inhibitors
-
申请号： US10505796申请日： 2003-02-28
-
公开(公告)号： US07375134B2公开(公告)日： 2008-05-20
- 发明人: Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien
- 申请人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien
- 申请人地址： US CA South San Francisco CA Quebec
- 专利权人： Axys Pharmaceuticals, Inc.,Merck Frosst Canada & Co.
- 当前专利权人： Axys Pharmaceuticals, Inc.,Merck Frosst Canada & Co.
- 当前专利权人地址： US CA South San Francisco CA Quebec
- 代理商 Nicole M. Beeler; David A. Muthard
- 国际申请： PCT/US03/06147 WO 20030228
- 国际公布： WO03/075836 WO 20030918
- 主分类号： A01N37/34
- IPC分类号： A01N37/34
摘要：
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
公开/授权文献
- US20050240023A1 Cathepsin cysteine protease inhibitors 公开/授权日：2005-10-27